Germany has opened a comparative routine-care evidence procedure for nadofaragene in bladder cancer, putting real-world evidence design in focus. https://www.mattheneus.com/editorial/g-ba-nadofaragene-bladder-cancer-real-world-evidence-collection-procedure-2026-10-01 #HTA #RWE

If you are going to talk new kids on the block, you'd expect #elacestrant and the Marsden don't let us down reporting their #RWE in poster 36. No PFS data reported but they do report toxicity. I was surprised to see 37% nausea reported.

No surprise to also see some adjuvant #ribociclib posters. Too early (and too small numbers for single centre data) to have outcomes. But some #RWE suggesting more transaminitis (but n=10) in the real world from poster 49 at UCL.

As with my #AI 🧵from #BOPA2026 there is a Real World Outcomes #RWO/#RWE theme running through some posters. I notice people don't know where to put these - are they audit (but against what standard?), are they research (but are the results generalisable?) or should they have their own category?

Preregistration is moving to the centre of credible real-world evidence, with change histories making analytical decisions auditable. https://www.mattheneus.com/editorial/joint-rwe-transparency-statement-preregistration-change-history-2026-09-29 #HTA #RWE #RegulatoryAffairs

AI in older-adult care needs measured technology costs before its value case can be trusted. #HTA #HealthEconomics #RWE https://www.mattheneus.com/editorial/ai-older-adult-care-economic-evaluation-cost-validation-gaps-2026-10-01

A new tutorial brings model-form uncertainty into observational cost-effectiveness analysis with nonparametric regression. https://www.mattheneus.com/editorial/nonparametric-regression-observational-cost-effectiveness-model-form-2026-10-01 #HTA #RWE #HealthEconomics

Rwanda triaged 136 cancer interventions to decide which ones actually needed a new cost-effectiveness model. https://www.mattheneus.com/editorial/adaptive-health-technology-assessment-decision-risk-chart-benefits-package-2026-10-01 #HTA #HealthEconomics #RWE

Viel Spaß mit unserer neuen Folge 🎧🇮🇩:

Folge #149 Saison 2026/27 Spieltag 11 LOK – RWE

Webseite🌍: erfurterfancast.podigee.io/149-saison-2...
RSS Feed📻: erfurterfancast.podigee.io/feed/mp3

#FCRWE #RWE #erfurterfancast #rotweißerfurt #SWK #steigerwaldkurve

Neuer Beitrag: 50 Jahre „Immer Ärger mit den Jungs aus der Westkurve“ https://www.jawattdenn.de/jawattdenn/weisste-noch/50-jahre-immer-aerger-mit-den-jungs-aus-der-westkurve.html
#jawattdenn #nurderRWE #RWE

#RWE is begin dit jaar volledig overgestapt van kolen op biomassa. Onderzoek van Zembla laat zien dat bij een Maleisische leverancier ook hele bomen worden verwerkt tot pellets. RWE heeft bevestigd dat dit sinds dit jaar gebeurt. Een boom is geen kolen. Maar verbranden maakt hem niet duurzaam. [2/4]

New article about #RWE burning wood pellets linked to rainforest destruction in Malaysia in its Dutch power stations. As is Albioma in Reunion, a French overseas territory, too:

environmentalpaper.org/2026/09/rwe-...

Trajectories or transition probabilities? The engine choice decides what a therapy-sequence ICER can represent. https://www.mattheneus.com/editorial/ehr-microsimulation-trajectory-multistate-therapy-sequence-cost-effectiveness-2026-09-30 #HTA #HealthEconomics #RWE

Germany has cleared secondary use of cervical screening programme data to study why participation lags. Registry access as evidence infrastructure. https://www.mattheneus.com/editorial/g-ba-cervical-screening-secondary-data-use-approval-participation-2026-09-24 #HTA #RWE #EvidenceSynthesis

Germany's G-BA approves secondary use of cervical screening data for a participation study — a notable step for real-world data access policy. #HTA #RWE #HealthEconomics https://www.mattheneus.com/editorial/g-ba-cervical-screening-secondary-data-use-approval-participation-2026-09-24

Join us Wednesday, September 30th at 4:30 PM PT for the American Educational Research Association Research on Women in Education Hispanic/Latinx Heritage Webinar. #AERA #RWE #YourStoryMatters #HispanicHeritageMonth #EdBranding #TheCirclesWeKeep
Register:
bit.ly/3VKtO9h
#EduSky

Transparency in research enables the public and decision makers to trust the science that underpins real-world evidence (#RWE). Toward this objective, ISPOR and ISPE have published a joint RWE Transparency Position Statement. #healthcare
https://ow.ly/SNea50ZOTWP

Australia's reimbursement committee flags three cancer trials where overall survival data moved after listing. https://www.mattheneus.com/editorial/pbac-overall-survival-monitoring-system-cancer-medicines-red-alert-trials-2026-09-29 #HTA #RWE #HealthEconomics

Throughout 2025, Teamit's Health Data Unit supported studies, networks and initiatives that help generate robust#RWE for public health and regulatory decision-making across Europe.
📖 Take a closer look at our Health Data activities: https://loom.ly/02ZndCs

Clone every patient into every strategy, then censor and weight: it is how treatment-timing comparisons keep index dates aligned and avoid immortal time. https://www.mattheneus.com/editorial/clone-censor-weight-treatment-timing-index-date-alignment-2026-09-28 #HTA #RWE #EvidenceSynthesis